AU2575601A - Extracellular matrix and cell adhesion molecules - Google Patents
Extracellular matrix and cell adhesion moleculesInfo
- Publication number
- AU2575601A AU2575601A AU25756/01A AU2575601A AU2575601A AU 2575601 A AU2575601 A AU 2575601A AU 25756/01 A AU25756/01 A AU 25756/01A AU 2575601 A AU2575601 A AU 2575601A AU 2575601 A AU2575601 A AU 2575601A
- Authority
- AU
- Australia
- Prior art keywords
- extracellular matrix
- cell adhesion
- adhesion molecules
- molecules
- extracellular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000016289 Cell Adhesion Molecules Human genes 0.000 title 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 title 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title 1
- 210000002744 extracellular matrix Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17285299P | 1999-12-10 | 1999-12-10 | |
US60172852 | 1999-12-10 | ||
US17235499P | 1999-12-16 | 1999-12-16 | |
US60172354 | 1999-12-16 | ||
PCT/US2000/032990 WO2001042285A2 (en) | 1999-12-10 | 2000-12-05 | Extracellular matrix and cell adhesion proteins as well as genes encoding them |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2575601A true AU2575601A (en) | 2001-06-18 |
Family
ID=26867999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25756/01A Abandoned AU2575601A (en) | 1999-12-10 | 2000-12-05 | Extracellular matrix and cell adhesion molecules |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1244695A2 (en) |
JP (1) | JP2005503751A (en) |
AU (1) | AU2575601A (en) |
CA (1) | CA2390093A1 (en) |
WO (1) | WO2001042285A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6623923B1 (en) | 1998-12-23 | 2003-09-23 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
AU2375800A (en) | 1998-12-23 | 2000-07-31 | Immunex Corporation | Lectin s3939 dna and polypeptides |
AU2387900A (en) * | 1998-12-23 | 2000-07-12 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
WO2001049716A2 (en) * | 1999-12-30 | 2001-07-12 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
AUPR470101A0 (en) * | 2001-05-02 | 2001-05-24 | Murdoch Childrens Research Institute, The | A molecular marker |
AU2002360514A1 (en) * | 2001-12-07 | 2003-06-23 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt | hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY |
CA2481039A1 (en) * | 2002-04-01 | 2003-10-16 | Curagen Corporation | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
RU2730661C2 (en) * | 2018-12-27 | 2020-08-24 | Селл энд Джин Терапи Лтд | Gene-therapeutic dna-vector based on gene-therapeutic dna-vector vtvaf17, carrying target gene selected from group of genes col1a1, col1a2, p4ha1, p4ha2, col7a1, clca2, eln, plod1 to increase level of expression of said target genes, method for production and use thereof, strain escherichia coli scs110-af/vtvaf17-col1a1, or escherichia coli scs110-af/vtvaf17-col1a2, or escherichia coli scs110-af/vtvaf17-p4ha1, or escherichia coli scs110-af/vtvaf17-p4ha2, or escherichia coli scs110-af/vtvaf17-col7a1, or escherichia coli scs110-af/vtvaf17-clca2, or escherichia coli scs110-af/vtvaf17-eln, or escherichia coli scs110-af/vtvaf17- plod1, carrying gene-therapeutic dna vector, method for production thereof, method for industrial production of gene-therapeutic dna vector |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999063088A2 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Membrane-bound proteins and nucleic acids encoding the same |
AU5173400A (en) * | 1999-05-28 | 2000-12-18 | Sugen, Inc. | Protein kinases |
-
2000
- 2000-12-05 JP JP2001543582A patent/JP2005503751A/en active Pending
- 2000-12-05 AU AU25756/01A patent/AU2575601A/en not_active Abandoned
- 2000-12-05 EP EP00989218A patent/EP1244695A2/en not_active Withdrawn
- 2000-12-05 CA CA002390093A patent/CA2390093A1/en not_active Abandoned
- 2000-12-05 WO PCT/US2000/032990 patent/WO2001042285A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2390093A1 (en) | 2001-06-14 |
EP1244695A2 (en) | 2002-10-02 |
JP2005503751A (en) | 2005-02-10 |
WO2001042285A3 (en) | 2002-03-07 |
WO2001042285A2 (en) | 2001-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001273151A1 (en) | Human extracellular matrix and cell adhesion polypeptides | |
AU5129800A (en) | Extracellular matrix and adhesion-associated proteins | |
AU4993200A (en) | Fuel cell and membrane | |
AU5472099A (en) | Extracellular adhesive proteins, exadh1 and exadh2 | |
AU2454101A (en) | Electrochemical cell system | |
AU6303800A (en) | Improvements in or relating to polymers | |
AU3429800A (en) | Flat electrochromic contrast system | |
AU3716499A (en) | Substituted diamines and their use as cell adhesion inhibitors | |
AU2002246422A1 (en) | Cell culture plate and system using the same | |
AU2716299A (en) | Electrochrome cell | |
AUPP995799A0 (en) | Improvements in hinges | |
AU3931400A (en) | N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators | |
AU5320700A (en) | Novel toll molecules and uses therefor | |
AU5124699A (en) | Molecules associated with cell proliferation | |
AU4351000A (en) | Cellular matrix system and use thereof | |
AU2575601A (en) | Extracellular matrix and cell adhesion molecules | |
AU2565601A (en) | Polymer gel electrolyte | |
AU6179400A (en) | Multi-photodetector unit cell | |
AU2002351194A1 (en) | Cell adhesion and extracellular matrix proteins | |
AU4391900A (en) | Electrochemical cell | |
AU2003295824A1 (en) | Cell adhesion and extracellular matrix proteins | |
AU2003265431A1 (en) | Cell adhesion and extracellular matrix proteins | |
AU2424897A (en) | Human epithelial cell matrix and uses therefor | |
AU2002308567A1 (en) | Cell adhesion and extracellular matrix proteins | |
AU2228501A (en) | Hydrogenated styrene polymer and optical-disk substrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |